Breast adenocarcinoma
Therapeutic area
Dermatology
Rare disease
No
- Definition
- A carcinoma that arises from glandular epithelial cells of the breast
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Breast adenocarcinoma
- Therapeutic area
- Dermatology
- breast adenocarcinoma
- adenocarcinoma of breast
- adenocarcinoma of the breast
- breast adenocarcinoma
- mammary adenocarcinoma
- Severity
- Severe
- Dermatology
- Oncology
- MONDO ID
- MONDO:0004988
- Parent condition
- MONDO:0000653
Related records
Broader conditions (20)
- Adenocarcinoma
- Breast cancer
- Breast carcinoma
- Breast disorder
- Breast neoplasm
- Cancer
- Cancer or benign tumor
- Carcinoma
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Epithelial neoplasm
- Glandular cell neoplasm
- Human disease
- Integumentary system cancer
- Integumentary system disorder
- Neoplasm
- Neoplasm of thorax
- Neoplastic disease or syndrome
- Thoracic cancer
Narrower conditions (34)
- Acinic cell breast carcinoma
- Adenoid cystic breast carcinoma
- Basal-like breast carcinoma
- Breast apocrine carcinoma
- Breast columnar cell mucinous carcinoma
- Breast cystic hypersecretory carcinoma
- Breast ductal adenocarcinoma
- Breast lobular carcinoma
- Breast malignant eccrine spiradenoma
- Breast mucinous carcinoma
- Breast mucinous cystadenocarcinoma
- Breast papillary carcinoma
- Breast secretory carcinoma
- CTNNA1-related diffuse gastric and lobular breast cancer syndrome
- Ductal breast carcinoma in situ
- Glycogen-rich clear cell breast carcinoma
- Inflammatory breast carcinoma
- Intraductal cribriform breast adenocarcinoma
- Invasive ductal and lobular carcinoma
- Invasive ductal breast carcinoma
Trials (58)
- A Prospective, Multicenter Registry to Observe the Treatment Patterns, Clinical Outcomes, and Decision-Making in Patients With Early Breast Cancer Eligible for EndoPredict® Testing
- A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer
- A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer
- Adjuvant Chemotherapy With Epirubicin, CMF, and Weekly Docetaxel or Weekly Paclitaxel in Patients With Resected High-risk Breast Cancer
- Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer
- Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy
- Carbon Dioxide Fractional Laser in Treating Participants With Stage 0-III Hormone Receptor-Positive Breast Cancer With Vulvovaginal Atrophy
- Cicaderma Efficacy vs Standard Care of Sites in Preventing Radiodermatitis in Non-metastatic Breast Cancer Patients
- CR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast Cancer
- Definitive Radiation Therapy for Inoperable Breast Cancer
- Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer
- Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility
- Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
- Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
- Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer
- Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer
- Effects of Chemotherapy Treatment on Metaboreflex, Mechanoreflex, and Baroreflex Function: PROTECT-08B Study
- Effects of Probiotics on the Gut Microbiome and Immune System in Operable Stage I-III Breast or Lung Cancer
- Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast Cancer
- Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy